References
On the Science of Essential Nutrients
Bliznakov, E.G. (1973). Effect of stimulation of the host defense system
by coenzyme Q10 on dibenzpyrene-induced tumors and infection with Friend
leukemia virus in mice. Proc. Natl. Acad. Sci. USA 70, 390-4.
Cathcart,
R.F. (1980). The method for determining proper doses of vitamin C for the
treatment of disease by titrating to bowel tolerance. Australasian Nurses J.
9(4), 9-13.
Cathcart, R.F. (1981). Vitamin C, titrating to bowel
tolerance, anascorbemia, and acute induced scurvy. Medical Hypotheses, 7,
1359-76. (http://www.orthomed.com)
Cathcart, R.F. (1984). Vitamin C in
the treatment of acquired immune deficiency syndrome (AIDS). Medical Hypotheses,
14(4), 423-33.
Cilento, P. (1973). The truth about vitamin E.Woman's Day,
12 November.
Chakrabarti, B. and Bannerjee, S. (1955). Dehydroascorbic
acid level in blood of patients suffering from various infectious diseases.
Proc. Soc. Exper. Biol. Med. 88, 581-3.
Chatterjee, I.B. and Bannerjee A.
(1979). Estimation of dehydroascorbic acid in blood of diabetic patients. Anal.
Biochem. 98, 368-74.
Cooper, M.R., McCall, C.E. and DeChatelet, L.R.
(1971). Stimulation of leukocyte hexose monophosphate shunt activity by ascorbic
acid. Infect Immun, 3, 851-3.
Cousins, L. (1983). Congenital anomalies
among infants of diabetic mothers: Etiology, prevention, prenatal diagnosis. Am.
J. Obstet. Gynecol. 147(3), 333-8.
Denson, K.W. and Bowers, E.F. (1961).
The determination of ascorbic acid in white blood cells. Clin Sci, 21,
157-62.
Ely, J.T.A. (1981) Hyperglycemia and major congenital anomalies,
New Engl. J. Med., 305(14), 833.
Ely, J.T.A. (1996). Glycemic modulation
of tumor tolerance. J. Orthomolecular Med. 11(1), 23-34.
Ely, J.T.A.
(1999). Ascorbic acid and some other modern analogs of the germ theory. J.
Orthomolecular Med. 14(3),143-56.
Ely, J.T.A., Fudenberg, H.H.,
Bliznakov, E.G., Branch, J.D. (1998). Hemorrhagic Stroke in Human Pretreated
with Coenzyme Q10: Exceptional Recovery as Seen in Animal Models. J.
Orthomolecular Med. 13(2), 105-109.
Ely JTA, Fudenberg HH, Muirhead RJ,
LaMarche MG, Krone CA, Buscher D, Stern EA. (1999). Urine mercury in
micromercurialism: bimodal distribution and diagnostic implications. Bull
Environ Contam Toxicol. 63(5):553-59.
Ely JTA, Krone CA. (2000). A brief
update on ubiquinone (Coenzyme Q10) J Orthomolecular Med
15(2):63-68.
Esterbauer, H., Dieber-Rothender, M. and Striegl, G. (1991).
Role of vitamin E in preventing oxidation of low-density lipoprotein. Am. J.
Clin. Nutr. 53, 314s-21s.
Gey, K.F., Puska, P., Jordan, P. and Moser, U.
(1991). Inverse correlation between plasma vitamin E and mortality from ischemic
heart disease in cross-cultural epidemiology. Am. J. Clin. Nutr. 53,
326s-34s.
Hamel, E.E., Santisteban, G.A., Ely, J.T.A. and Read, D.H.
(1986). Hyperglycemia and reproductive defects in non-diabetic gravidas: a mouse
model test of a new theory. Life Sci. 39, 1425-8.
Harman D: Prolongation
of life: role of free radical reactions in aging. J Am Geriatr Soc. 1969; Aug;
17(8): 721-35.
Harman D. (1969). Prolongation of life: role of free
radical reactions in aging. J Am Geriatr Soc.17(8): 721-35.
Harman D.
(1981). The aging process. Proc Natl Acad Sci U S A. 78(11):
7124-8.
Harman D. (1972). The biological clock: The mitochondria? J Am
Geriatr Soc. 20(4):145-47.
Harman D. (2001) Aging: Overview. Ann NY Acad
Sci 928:1-21.
Hume, R., Weyers, W., Rowan, T., Reid, D.S., Hillis, W.S.
(1972). Leucocyte ascorbic acid levels after acute myocardial infarction. Brit.
Heart J. 34, 238-43.
Klenner, F.R. (1949). The treatment of poliomyelitis
and other virus diseases with vitamin C. Southern Med. Surg. 111,
209-14.
Klenner, F.R. (1971). Observations on the dose and administration
of ascorbic acid when employed beyond the range of a vitamin in human pathology.
J. Appl. Nutr. 23, 61-88. (see http://www.orthomed.com)
Klenner, F.R.
(1974). Significance of high daily intake of ascorbic acid in preventive
medicine. J. Prev. Med. Spring, 45-69. (see
http://www.orthomed.com)
Koroljow, S. (1962). Insulin coma therapy.
Psychiatric Quarterly 36, 261-70.
Krone CA, Elmer GW, Ely JTA, Fudenberg
HH, Thoreson J. (2001). Does gastrointestinal Candida albicans prevent
ubiquinone absorption? Med Hypoth. 57(5):570-72.
Langsjoen, P.H. (1995).
Introduction to Coenzyme Q10. On web site
http://faculty.washington.edu/ely
Langsjoen PH, Langsjoen AM. (1999)
Overview of the use of CoQ10 in cardiovascular disease. BioFactors 9:273-84.
(can be found at http://wwwcsi.unian.it/coenzymeQ/overview.html).
Lewin,
S. (1976). Vitamin C: Its Molecular Biology and Medical Potential. New York,
Academic Press, p.109.
Marshall, J.C., Christou, N.V., Horn, R., Meakins,
J.L. (1988). The microbiology of multiple organ failure. The proximal
gastrointestinal tract as an occult reservoir of pathogens. Arch. Surg .123,
309-15.
Pauling, L.J. (1987). How to live longer and feel better. Avon
Books, New York, pp.413.
Relman, A.S., (1992). Reforming our health care
system: A physician's perspective. Phi Beta Kappa Key Reporter 58(Autumn),
1-5.
Santisteban, G.A., Ely, J.T.A., Hamel, E.E., Read, D.H. and Kozawa,
S.M. (1985). Glycemic modulation of tumor tolerance in a mouse model of breast
cancer. Biochem. Biophys. Res. Commun. 132(3), 1174-9.
Shute, W.E.
(1975). Dr Wilfred Shute's complete updated vitamin E book. Keats Publish., New
Canaan CT, pp. 255.
Sirsi, M. (1952). Antimicrobial action of vitamin C
on M. tuberculosis and some other pathogenic organisms. Indian J. Med. Sci.
(Bombay) 6, 252-5.
Stone, I. (1972). The Healing Factor. Grosset &
Dunlap, New York, pp. 258.
Watson, T.J. Jr. (1973). Health Service. J.
Am. Soc. Prev. Dent. 3(1), 12-3.
On the Science of
Essential Nutrients
Updated September 2002